Get the Stockscreener App
48.51
5.53%
-2.84
After Hours:
48.75
0.24
+0.49%
Procept Biorobotics Corp stock is traded at $48.51, with a volume of 1.14M.
It is down -5.53% in the last 24 hours and down -15.78% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$51.35
Open:
$50.715
24h Volume:
1.14M
Relative Volume:
1.24
Market Cap:
$2.68B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-28.54
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-17.27%
1M Performance:
-15.78%
6M Performance:
-33.09%
1Y Performance:
-23.39%
1-Day Range:
$48.47
$51.38
1-Week Range:
$48.47
$58.87
52-Week Range:
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
48.51 | 2.84B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Is it the right time to buy PROCEPT BioRobotics Corporation stockDaily Trading Insights With High Returns - jammulinksnews.com
Is PROCEPT BioRobotics Corporation a growth stock or a value stockAdvanced Screener Growth Plan For Every Investor - jammulinksnews.com
When is PROCEPT BioRobotics Corporation stock expected to show significant growthChart Pattern Data Feed For Beginners - jammulinksnews.com
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Published on: 2025-07-29 00:15:20 - metal.it
Buy Rating Affirmed for PROCEPT BioRobotics Amid Strategic Leadership and Strong Financial Performance - TipRanks
Why is PROCEPT BioRobotics Corporation stock attracting strong analyst attentionCapitalize on market trends with confidence - jammulinksnews.com
How strong is PROCEPT BioRobotics Corporation company’s balance sheetBuild wealth faster with expert stock picks - jammulinksnews.com
How does PROCEPT BioRobotics Corporation compare to its industry peersFree Investment Timing Strategies - jammulinksnews.com
How does PROCEPT BioRobotics Corporation generate profit in a changing economyAchieve triple-digit returns with smart investing - jammulinksnews.com
What makes PROCEPT BioRobotics Corporation stock price move sharplyFree Stock Selection - metal.it
Procept BioRobotics down after CEO retirement - MSN
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionLow Risk Consistent Winners - metal.it
Procept BioRobotics' Leadership Transition: A Strategic Inflection Point or a Missed Opportunity? - AInvest
Navigating Leadership Transitions: Assessing the Impact of CEO Change on Procept BioRobotics' Growth Trajectory - AInvest
Procept BioRobotics' CEO Transition: A Catalyst for Short-Term Volatility or Long-Term Value? - AInvest
Procept Biorobotics stock falls after CEO succession announcement By Investing.com - Investing.com India
Procept Biorobotics stock falls after CEO succession announcement - Investing.com Australia
Edwards Exec Larry Wood Departs for Procept BioRobotics - Orange County Business Journal
Procept BioRobotics Plunges 9.6%, What’s Next for This Surgical Robotics Contender? - AInvest
Leadership Change and Revenue Surge Shake PROCEPT BioRobotics - TipRanks
Procept BioRobotics (PRCT) Shares Drop Amid CEO Transition - GuruFocus
Edwards loses longtime TAVR leader Larry Wood - MedTech Dive
Procept BioRobotics stock down on CEO exit (PRCT:NASDAQ) - Seeking Alpha
What analysts say about PROCEPT BioRobotics Corporation stockUnmatched market gains - Autocar Professional
Procept BioRobotics CEO Reza Zadno reitiring, Larry Wood to succeed - MSN
PROCEPT BioRobotics Appoints New CEO Larry L. Wood - TipRanks
Procept Biorobotics CEO to retire, Edwards VP, TAVR head named as successor - MassDevice
Procept Biorobotics Corporation Announces Executive Changes - MarketScreener
Is PROCEPT BioRobotics Corporation stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com
PROCEPT BioRobotics: Promising Growth Under New Leadership and Attractive Valuation - TipRanks
What drove PRCT's earnings growth in 2024? - AInvest
What's the outlook for PRCT's Q1 2025 earnings? - AInvest
Why did PRCT's Q3 earnings exceed forecasts? - AInvest
Larry Wood to join PROCEPT BioRobotics as CEO, company reports 48% revenue growth - Investing.com
Larry Wood to Lead Procept BioRobotics (PRCT) as New CEO | PRCT Stock News - GuruFocus
Procept BioRobotics (PRCT) Exceeds Q2 Revenue Projections | PRCT Stock News - GuruFocus
Larry L. Wood Appointed CEO of PROCEPT BioRobotics; Company Pre-Announces 48% Revenue Growth for 2Q25 - Nasdaq
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to - GlobeNewswire
PROCEPT BioRobotics Achieves 48% Revenue Surge to $79.2M as Edwards Lifesciences Veteran Takes CEO Role - Stock Titan
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy - GlobeNewswire
What drives PROCEPT BioRobotics Corporation stock priceRapid-fire capital growth - jammulinksnews.com
Redefining Prostate Cancer Care: How PROCEPT BioRobotics' Aquablation Therapy Could Disrupt Urology and Unlock a $10B+ Market - AInvest
PROCEPT BioRobotics (PRCT) Achieves Milestone in Prostate Cancer Trial | PRCT Stock News - GuruFocus
Is PROCEPT BioRobotics Corporation a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Groundbreaking Prostate Cancer Treatment Trial Achieves Same-Day Discharge Success in Surgery Center - Stock Titan
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):